Action ENTA ENANTA PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Enanta Pharmaceuticals, Inc.

Actions

ENTA

US29251M1062

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 17/07/2024 		Varia. 5j. Varia. 1 janv.
15,82 USD -2,04 % Graphique intraday de Enanta Pharmaceuticals, Inc. +8,36 % +68,12 %
07/05 ENANTA PHARMACEUTICALS, INC. : JMP Securities optimiste sur le dossier ZM
06/05 Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
D. Mass. Patent Litigation Update: May 2024
AQ
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
BU
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
BU
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
AQ
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
BU
Enanta Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
BU
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
BU
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
BU
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
BU
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
AQ
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
BU
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
BU
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
BU
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
BU
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BU
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
BU
Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot
AQ
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
BU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ENTA
  4. Actualités Enanta Pharmaceuticals, Inc.
  5. Communiqués